GGrantIndex
← Leaderboards

Ian Ronald Corbin

Ut Southwestern Medical Center

$3,266,102
Attributed
$3,266,102
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $491.1K · FY201725
$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,266,102 · 2

By mechanism

R01$3,266,102 · 2

Top collaborators

No co-investigators on record.

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Liver Neoplasms

Research focus

Liver NeoplasmsMalignant NeoplasmsInjuryLiver FunctionMalignant Epithelial CellMalignant Neoplasm Of LiverFluoroscopyHepatocyteLiverLiver DiseasesIncidenceLow-Density LipoproteinsDoseImage GuidedEngineeringConsumptionCatheterizationExtensive NecrosisHepatic ArteryChemoembolizationDiagnosisFunding OpportunitiesDocosahexaenoic AcidsMolecular

Grant awards (9)

Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.$491,106
R01 · FY2025 · CA · contact PI
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.$415,130
R01 · FY2024 · CA · contact PI
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.$436,977
R01 · FY2023 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2021 · CA · contact PI
Image Guided Delivery and Evaluation of Low-Density Lipoprotein- Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma -Diversity Supplement$81,132
R01 · FY2021 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2020 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$359,457
R01 · FY2019 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2018 · CA · contact PI
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma$370,575
R01 · FY2017 · CA · contact PI